ArticleBMC pharmacology & toxicology2023

Correction to: efficacy and safety of the switch of Triumeq® to generic (abacavir + lamivudine) + Tivicay®: data at 24 weeks.

Julián Olalla et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.